Kyndryl is trading as if the worst-case version of its story is already playing out, and the evidence does not yet support that reading. The stock stands near $13, roughly two-fifths off its high of a year ago, at a market capitalization of $2.85 billion. The company guides the coming fiscal year to adjusted pretax income of $600 million to $700 million, a multiple on that number of barely five times. The gap between price and the guided economics exists because the filings have layered a cash-management investigation by the SEC's enforcement division, a second round of internal control material weaknesses, a C-suite revolving door, and a blocked bolt-on acquisition on top of a business whose revenue has now declined for three straight fiscal years. The market is pricing a franchise in freefall; the operating data it is actually delivering is closer to a managed contraction with a growth engine that keeps compounding.
The single most important recent development is the workforce rebalancing charge of $152 million booked in the first quarter, the first of roughly $200 million in total charges that management now frames as a one-time structural reset rather than another quarterly trimming exercise. The mechanism is the same one that has worked since the spin from IBM: cut the low-margin, pre-spin legacy work, and let the higher-margin new signings and the hyperscaler and advisory book carry the mix. The same quarter, trailing twelve-month signings reached $14.2 billion, while the consulting book grew double digits for the year. Hyperscaler-related revenue grew 34 percent, exiting at a run rate above $2.1 billion. The revenue base is shrinking, but the revenue that replaces it is meaningfully better.
The counterweight is real and should not be waved away. The SEC enforcement investigation into Kyndryl's cash management practices is still open with no stated outcome, the internal control material weaknesses tied to disclosure processes and the reporting hotline remain unremediated as of June 30, and the company's own liquidity math depends on a revolving credit extension and the orderly refinancing of $700 million of notes maturing in October. Cash from operations was a $310 million use in the first quarter, and the company is repurchasing stock out of the same pot while a third CFO has now been installed in six months. None of this is fatal on its own; together it argues for treating Kyndryl as a restructuring trade with governance risk, not as the clean multiple-compression value story the multiple implies.
The variables that decide the case are the trajectory of constant-currency revenue toward the guided low-single-digit decline, whether the run-rate cost savings actually lands in the following year, the status of the enforcement matter, and the conversion of signings into billable revenue. The October notes maturity and the November expiration of the extended revolver borrowing set the near-term liquidity checkpoints.